Transcript
Page 1: How can patients and providers best contribute Simone ... · How can patients and providers best contribute to the HTA process Sime Warren, National Health Care Institute of the Netherlands,

European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu

How can patients and providersbest contribute tothe HTA process

Sime Warren, National Health Care Institute of the Netherlands, Diemen, the NetherlandsAnna Nachtnebel, Ludwig Boltzmann Institute for HTA, Vienna, AustriaWP5 - Applying the HTA Core Model for Rapid Assessment for national adaptation andreporting

Third WP2 Face to Face Training Course for EUnetHTA stakeholders, Brussels, 23rd of April2015

Page 2: How can patients and providers best contribute Simone ... · How can patients and providers best contribute to the HTA process Sime Warren, National Health Care Institute of the Netherlands,

European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.euEuropean network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu

Stakeholder involvementStrand A and Strand B

2

Page 3: How can patients and providers best contribute Simone ... · How can patients and providers best contribute to the HTA process Sime Warren, National Health Care Institute of the Netherlands,

Stakeholder Involvement Strand A

Closecollaboration

with theparticipatingmanufacturer

Update of theHTA Core Modelapplication for

REAsStakeholder and

publicconsultation

Feedback session withmanufacturer about the

draft submissiontemplate (WP7)

Page 4: How can patients and providers best contribute Simone ... · How can patients and providers best contribute to the HTA process Sime Warren, National Health Care Institute of the Netherlands,

May 8, 2015European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu 4

Stakeholder Involvement Strand B

Page 5: How can patients and providers best contribute Simone ... · How can patients and providers best contribute to the HTA process Sime Warren, National Health Care Institute of the Netherlands,

European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu

Compilation of final project plan

Stakeholder Advisory Group & Stakeholder Forum: informed aboutupcoming public consultation of project plan, inquiry to suggest externalmedical experts, patients representatives, identification of manufacturers

Manufacturer(s): informed about upcoming public consultation of projectplan, to submit evidence/information on reimbursement status, submissionfile, scoping meeting(?)

Patients: scoping - selection of relevant outcomes, comparators, draftproject plan

Medical experts: scoping - selection of relevant outcomes, comparators,draft project plan

Public: draft project plan

Stakeholder involvement - Scoping Phase

Page 6: How can patients and providers best contribute Simone ... · How can patients and providers best contribute to the HTA process Sime Warren, National Health Care Institute of the Netherlands,

European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu

Production of final assessment

Manufacturer(s), patients, medical experts: opportunityto comment on second draft of assessment, comments &answers publicly available

Further involvement

Update of HTA Core Model for Rapid REA

Stakeholder involvement - Assessment Phase

6

Page 7: How can patients and providers best contribute Simone ... · How can patients and providers best contribute to the HTA process Sime Warren, National Health Care Institute of the Netherlands,

European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu

1. Where do you think stakeholder involvement ismost relevant?

2. Could you think of other ways of stakeholderinvolvement?

Plenary session Strand A and Strand B

7

Page 8: How can patients and providers best contribute Simone ... · How can patients and providers best contribute to the HTA process Sime Warren, National Health Care Institute of the Netherlands,

European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu

Thank you!

This presentation arises from the EUnetHTA

Joint Action 2 which has received fundingfrom the European Union, in the framework ofthe Health Programme


Recommended